Table 2.
Patient clinical characteristics.
| N. (%) | |
|---|---|
| Age: median value (range, IQR) | 53 (34-71, 47-60) |
| Family history of cancer | |
| No | 46 (61.3) |
| Yes | 29 (38.7) |
| Bilateral tumors | |
| No | 72 (96.0) |
| Yes | 3 (4.0) |
| Stage | |
| I | 25 (33.3) |
| II | 31 (41.4) |
| III | 19 (25.3) |
| Anthracycline therapy: | |
| No | 11 (14.7) |
| Yes | 64 (85.3) |
| Neoadjuvant chemotherapy | |
| No | 42 (56.0) |
| Yes | 33 (44.0) |
| Pathological complete response (pCR) | |
| Yes | 11 (33.0) |
| No | 22 (67.0) |
| Adjuvant chemotherapy | |
| No | 23 (30.7) |
| Yes | 52 (69.3) |
List of the patient’s clinical characteristics. The table shows family history of cancer, presence of tumor bilaterality, tumor stage, treatment data, and response to therapy. N: number, IQR: interquartile range.